📅 Dates: Friday–Saturday, October 3–4, 2025 | 📍 Venue: Philadelphia Convention Center
The WIN Symposium brings together leaders in precision medicine to explore cutting-edge topics spanning multi-omics, AI in oncology, spatial biology, liquid biopsies, MRD, and real-world clinical translation. Co-chaired by Andrea Ferreira-Gonzalez, Wafik S. El-Deiry, MD, PhD, FACP (WIN Chair), and Razelle Kurzrock, MD, FACP.
Day 1 – Friday, October 3
7:30–8:45 Registration & Check-in
8:45–9:00 Welcome & Introduction
9:00–9:40 Keynote Lecture – WIN Consortium
Targeting the Achilles’ Heel of Cancer: Synthetic Lethality & Hypoxia
by William G. Kaelin, Jr., MD (2019 Nobel Laureate; Harvard Medical School & Dana-Farber).
Session 1 · 9:40–10:40
- AI & Omics in Precision Oncology: clinical decision support (Caris Life Sciences), integrating omics & AI (Keith T. Flaherty), and an RWD + AI panel moderated by ConcertAI.
- Parallel: Multi-omics approaches (Yale, Ignite Proteomics, Microsoft Research, Illumina) + panel.
10:40–11:10 Networking & Exhibits
Sessions 2–3 · 11:10–1:00
- Precision Cancer Consortium (J&J IM, Genentech, PMC, MGH/AACR).
- Tumor Plasticity & Resistance: radiation oncology modeling (Cleveland Clinic), EMT (Brown), molecularly defined subsets (Brown).
- Parallel: Spatial-omics applications (BIDMC/Harvard, Weill Cornell, 10x Genomics, Gilead) + panel; Industry perspectives (Akoya, 10x, Illumina).
1:00–1:50 Lunch
Session 4 · 1:50–4:10
- From Targets to Trials: targeted immunotherapies (Brown), early-phase profiling (MD Anderson), Q&A.
- Venture Philanthropy (Medical Excellence Capital) & Lung Cancer Diagnostics (Yale).
- Parallel: AI & Digital Pathology (Genentech, PathAI, Roche) → Omics into the Clinic (UQ, AstraZeneca, Yale, Akoya) + panel.
4:10–4:25 Break & Exhibits
Late Sessions · 4:25–6:45
- Pediatric Precision Oncology (Penn State, Wake Forest, UF, Mount Sinai, Caris) + MRD industry perspectives.
- Liquid Biopsies: resistance monitoring (City of Hope), clinical implementation (UC San Diego).
- Parallel Multi-omics (MD Anderson, BD Biosciences, Signios Bio) + Industry perspectives (Vizgen, Stellaromics, Signios).
6:15–7:15 Networking Reception
Day 2 – Saturday, October 4
7:30–8:30 Registration & Check-in
8:30–8:35 Welcome · Day 1 Recap
8:35–8:55 Keynote
Session 1 · 8:55–10:35
- Precision for All: WIN data science update (McGill), live international molecular tumor board (WIN co-chairs).
- Expanding the Frontier: immunotherapy biomarkers & trial innovation (Princess Margaret/AACR President), microbiome in cancer (Ventura Clinical Trials).
- Parallel: Precision therapy for rare disease (CHOP, Aayam Therapeutics, Utah Tech, BPGbio, ARPA-H).
10:35–11:00 Networking, Exhibits & Product Presentations
Session 3 · 11:00–1:05
- Advances in Precision Oncology: KRAS in pancreatic cancer (JHU, UPenn), genomics & future of care (Sarah Cannon), molecular pathology in urological cancers (Brown), epigenetic plasticity & resistance (Fox Chase) + panel.
- Parallel (Non-CME): Companion diagnostics—development, regulatory & commercialization (Health Advances, Merck, GSK, QIAGEN).
- 12:30–1:30: AI in Precision Medicine – SAPA of Greater Philadelphia.
1:05–2:00 Lunch
Session 4 · 2:00–3:30
- Precision Without Borders: building oncology infrastructure in LMICs (Mumbai), GIST co-targeting (Fox Chase), abstract winners.
- WIN Consortium Update 2025 with the WIN leadership.
🔗 Registration: Register Today
🤝 Sponsorship: Become a Sponsor
Source: Public agenda shared by Advancing Precision Medicine — WIN Symposium 2025.